Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-21

FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Buprenorphine HCl and Naloxone HCl from Amneal Pharmaceuticals LLC. The product is used for treating opioid use diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine HCl and Naloxone HCl (Buprenorphine and Naloxone)

Snippet

SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)